SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mira Keyes, Tom Pickles, Juanita Crook, Michael McKenzie, Arthur Cheung, Ingrid Spadinger, Vincent LaPointe, W. Francois Bachand, James Morris, Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy, Brachytherapy, 2015, 14, 3, 334

    CrossRef

  2. 2
    Yannick Lemaréchal, Julien Bert, Claire Falconnet, Philippe Després, Antoine Valeri, Ulrike Schick, Olivier Pradier, Marie-Paule Garcia, Nicolas Boussion, Dimitris Visvikis, GGEMS-Brachy: GPU GEant4-based Monte Carlo simulation for brachytherapy applications, Physics in Medicine and Biology, 2015, 60, 13, 4987

    CrossRef

  3. 3
    Jeffrey A. Kittel, Chandana A. Reddy, Kristin L. Smith, Kevin L. Stephans, Rahul D. Tendulkar, James Ulchaker, Kenneth Angermeier, Steven Campbell, Andrew Stephenson, Eric A. Klein, D. Allan Wilkinson, Jay P. Ciezki, Long-Term Efficacy and Toxicity of Low-Dose-Rate 125I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, 2015, 92, 4, 884

    CrossRef

  4. 4
    Andrea C. Lo, W. James Morris, Tom Pickles, Mira Keyes, Michael McKenzie, Scott Tyldesley, Patterns of Recurrence After Low-Dose-Rate Prostate Brachytherapy: A Population-Based Study of 2223 Consecutive Low- and Intermediate-Risk Patients, International Journal of Radiation Oncology*Biology*Physics, 2015, 91, 4, 745

    CrossRef

  5. 5
    Yasuhiro Yamada, Koji Masui, Tsuyoshi Iwata, Yasuyuki Naitoh, Kei Yamada, Tsuneharu Miki, Koji Okihara, Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: Outcome and toxicity, Brachytherapy, 2015, 14, 2, 118

    CrossRef

  6. 6
    Ingrid Spadinger, Jackson Chu, Maryam Afsari Golshan, Mira Keyes, Tom Pickles, Jeremy Hamm, W. James Morris, Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy, Brachytherapy, 2015, 14, 3, 350

    CrossRef

  7. 7
    Jim N. Rose, Juanita M. Crook, Tom Pickles, Mira Keyes, W. James Morris, Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity, Brachytherapy, 2015, 14, 3, 342

    CrossRef

  8. 8
    Narihiko Hayashi, Koji Izumi, Futoshi Sano, Yasuhide Miyoshi, Hiroji Uemura, Takeo Kasuya, Akiko Mukai, Masayuki Hata, Tomio Inoue, Ten-year outcomes of I125 low-dose-rate brachytherapy for clinically localized prostate cancer: a single-institution experience in Japan, World Journal of Urology, 2015,

    CrossRef

  9. 9
    Elisa K. Chan, Mira Keyes, Tom Pickles, Vincent Lapointe, Ingrid Spadinger, Michael McKenzie, W. James Morris, Decline in acute urinary toxicity: A long-term study in 2011 patients with prostate brachytherapy within a provincial institution, Brachytherapy, 2014, 13, 1, 46

    CrossRef

  10. 10
    Axel Heidenreich, Patrick J. Bastian, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Theodor van der Kwast, Malcolm Mason, Vsevolod Matveev, Thomas Wiegel, F. Zattoni, Nicolas Mottet, EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013, European Urology, 2014, 65, 1, 124

    CrossRef

  11. 11
    Simon S Lo, Andrew Loblaw, Eric L Chang, Nina A Mayr, Bin S Teh, Zhibin Huang, Min Yao, Rodney J Ellis, Tithi Biswas, Jason W Sohn, Mitchell Machtay, Arjun Sahgal, Emerging applications of stereotactic body radiotherapy, Future Oncology, 2014, 10, 7, 1299

    CrossRef

  12. 12
    David P Dearnaley, Gordana Jovic, Isabel Syndikus, Vincent Khoo, Richard A Cowan, John D Graham, Edwin G Aird, David Bottomley, Robert A Huddart, Chakiath C Jose, John H L Matthews, Jeremy L Millar, Claire Murphy, J Martin Russell, Christopher D Scrase, Mahesh K B Parmar, Matthew R Sydes, Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial, The Lancet Oncology, 2014, 15, 4, 464

    CrossRef

  13. 13
    Sarah Nicole Hamilton, Scott Tyldesley, Jeremy Hamm, Wei Ning Jiang, Mira Keyes, Tom Pickles, Vince Lapointe, Adam Kahnamelli, Michael McKenzie, Stacy Miller, W. James Morris, Incidence of Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy, International Journal of Radiation Oncology*Biology*Physics, 2014, 90, 4, 934

    CrossRef

  14. 14
    Mira Keyes, Stacy Miller, Tom Pickles, Ross Halperin, Winkle Kwan, Vincent Lapointe, Michael McKenzie, Ingrid Spadinger, Howard Pai, Elisa K. Chan, W. James Morris, Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric Goals, International Journal of Radiation Oncology*Biology*Physics, 2014, 90, 3, 570

    CrossRef

  15. 15
    J. Nicholas Lukens, Mauricio Gamez, Kenneth Hu, Louis B. Harrison, Modern Brachytherapy, Seminars in Oncology, 2014, 41, 6, 831

    CrossRef

  16. 16
    W. James Morris, Tom Pickles, Mira Keyes, Michael McKenzie, Ingrid Spadinger, Pride or prejudice: Does Phoenix flatter radiation therapy?, Brachytherapy, 2014, 13, 3, 299

    CrossRef

  17. 17
    Andrea C. Lo, W. James Morris, Vincent Lapointe, Jeremy Hamm, Mira Keyes, Tom Pickles, Michael McKenzie, Ingrid Spadinger, Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival, International Journal of Radiation Oncology*Biology*Physics, 2014, 88, 1, 87

    CrossRef

  18. 18
    Andrew Loblaw, The value of randomised trials for prostate cancer management, The Lancet Oncology, 2014, 15, 4, 374

    CrossRef

  19. 19
    W. James Morris, Ingrid Spadinger, Mira Keyes, Jeremy Hamm, Michael McKenzie, Tom Pickles, Whole prostate D90 and V100: A dose–response analysis of 2000 consecutive 125I monotherapy patients, Brachytherapy, 2014, 13, 1, 32

    CrossRef

  20. 20
    G.C. Morton, P.J. Hoskin, Brachytherapy: Current Status and Future Strategies — Can High Dose Rate Replace Low Dose Rate and External Beam Radiotherapy?, Clinical Oncology, 2013, 25, 8, 474

    CrossRef

  21. 21
    Richard Khor, Scott Williams, Contemporary Issues in Radiotherapy for Clinically Localized Prostate Cancer, Hematology/Oncology Clinics of North America, 2013, 27, 6, 1137

    CrossRef

  22. 22
    Mira Keyes, Calum MacAulay, Malcolm Hayes, Jagoda Korbelik, W. James Morris, Branko Palcic, DNA Ploidy Measured on Archived Pretreatment Biopsy Material May Correlate With Prostate-Specific Antigen Recurrence After Prostate Brachytherapy, International Journal of Radiation Oncology*Biology*Physics, 2013, 86, 5, 829

    CrossRef

  23. 23
    Annette Haworth, Scott Williams, Hayley Reynolds, David Waterhouse, Gillian M. Duchesne, Joseph Bucci, David Joseph, Sean Bydder, Martin Ebert, Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning, Brachytherapy, 2013, 12, 6, 628

    CrossRef